Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer

Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer

Wei Wang,1,* Jinyu Gu,1,* Yanxia Liu,2 Xiaoxu Liu,1 Lei Jiang,1 Changfen Wu,1 Jing Liu3 1Department of Obstetrics and Gynecology, Shijiazhuang Maternal and Child Health Care Hospital, Shijiazhuang, Hebei, 050000, People’s Republic of China; 2Department of Pediatrics, Shijiazhuang Mat...

Full description

Bibliographic Details
Main Authors: Wang W, Gu J, Liu Y, Liu X, Jiang L, Wu C, Liu J
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:Cancer Management and Research
Subjects:
epithelial ovarian cancer
cally index
biomarker
survival
Online Access:https://www.dovepress.com/pre-treatment-crp-albumin-lymphocyte-index-cally-index-as-a-prognostic-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/pre-treatment-crp-albumin-lymphocyte-index-cally-index-as-a-prognostic-peer-reviewed-fulltext-article-CMAR

Similar Items